Pyridoxamine, Advanced Glycation Inhibition, and Diabetic Nephropathy

被引：24
作者：
Chen, Joline L. T. [1 ]
Francis, Jean [1 ]
机构：
[1] Boston Univ, Sch Med, Renal Sect, Evans Biomed Res Ctr, Boston, MA 02118 USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2012年 / 23卷 / 01期
关键词：
END-PRODUCTS; EXPRESSION; PODOCYTE;
D O I：
10.1681/ASN.2011111097
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：6 / 8
页数：3
相关论文
共 23 条
  • [21] Effects of pyridoxamine in combined phase 2 studies of patients with type 1 and type 2 diabetes and overt nephropathy
    Williams, Mark E.
    Bolton, W. Kline
    Khalifah, Raja G.
    Degenhardt, Thorsten P.
    Schotzinger, Robert J.
    McGill, Janet B.
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 2007, 27 (06) : 605 - 614
  • [22] ADVANCED GLYCATION END-PRODUCTS UP-REGULATE GENE-EXPRESSION FOUND IN DIABETIC GLOMERULAR-DISEASE
    YANG, CW
    VLASSARA, H
    PETEN, EP
    HE, CJ
    STRIKER, GE
    STRIKER, LJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (20) : 9436 - 9440
  • [23] Reduced Expression of Lipoic Acid Synthase Accelerates Diabetic Nephropathy
    Yi, Xianwen
    Xu, Longquan
    Hiller, Sylvia
    Kim, Hyung-Suk
    Nickeleit, Volker
    James, Leighton R.
    Maeda, Nobuyo
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 23 (01): : 103 - 111
123